371
Views
0
CrossRef citations to date
0
Altmetric
Research Article

A study of anti-SARS-CoV-2 antibodies among healthcare personnel and the general population

, , , , , & show all
Article: 2256417 | Received 28 Jun 2023, Accepted 01 Sep 2023, Published online: 14 Sep 2023

References

  • WHO Coronavirus (COVID-19) Dashboard. Available from: https://covid19.who.int/.
  • Shreffler J, Petrey J, Huecker M. The impact of COVID-19 on healthcare worker wellness: a scoping review. West J Emerg Med. 2020; 21(5):1–5. doi: 10.5811/westjem.2020.7.48684.
  • Hiscott J, Alexandridi M, Muscolini M, et al. The global impact of the coronavirus pandemic. Cytokine Growth Factor Rev. 2020;53:1–9. doi: 10.1016/j.cytogfr.2020.05.010.
  • Peneva PA. Novel coronavirus—a challenge in diagnosing and timely treatment, and its impact on population health status. Folia Med (Plovdiv). 2021; 63(3):315–320. doi: 10.3897/folmed.63.e56228.
  • Marinov GK, Mladenov M, Rangachev A, et al. SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria. PLoS One. 2022;17(9):e0274509. doi: 10.1371/journal.pone.0274509.
  • Bergeri I, Whelan MG, Ware H, et al. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: a systematic review and meta-analysis of standardized population-based studies. PLoS Med. 2022;19(11):e1004107. doi: 10.1371/journal.pmed.1004107.
  • Chou R, Dana T, Buckley DI, et al. Epidemiology of and risk factors for coronavirus infection in health care workers: a living rapid review. Ann Intern Med. 2020;173(2):120–136. doi: 10.7326/M20-1632.
  • Tabah A, Ramanan M, Laupland KB, PPE-SAFE contributors., et al. Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): an international survey. J Crit Care. 2020;59:70–75. doi: 10.1016/j.jcrc.2020.06.005.
  • Müller SA, Wood RR, Hanefeld J, et al. Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence. Health Policy Plan. 2022;37(4):505–513. doi: 10.1093/heapol/czab133.
  • Grant R, Dub T, Andrianou X, et al. SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review. BMJ Open. 2021;11(4):e045425. doi: 10.1136/bmjopen-2020-045425.
  • Rostami A, Sepidarkish M, Fazlzadeh A, et al. Update on SARS-CoV-2 seroprevalence: regional and worldwide. Clin Microbiol Infect. 2021;27(12):1762–1771. doi: 10.1016/j.cmi.2021.09.019.
  • Ahmad AM, Shahzad K, Masood M, et al. COVID-19 seroprevalence in Pakistan: a cross-sectional study. BMJ Open. 2022;12(4):e055381. doi: 10.1136/bmjopen-2021-055381.
  • Breedon AME, Saldanha RJ, Salisbury RL, et al. COVID-19 seroprevalence and active infection in an asymptomatic population. Front Med (Lausanne). 2021;8:749732. doi: 10.3389/fmed.2021.749732.
  • Koelle K, Martin MA, Antia R, et al. The changing epidemiology of SARS-CoV-2. Science. 2022;375(6585):1116–1121. doi: 10.1126/science.abm4915.
  • Madureira R, Ferreira SA, Marion MAL, et al. Seroprevalence of SARS-CoV-2 in emergency department healthcare workers at Sírio-Libanês hospital, Brazil. Health Secur. 2022;20(5):359–367. doi: 10.1089/hs.2022.0045.
  • Sims MD, Maine GN, Childers KL, et al. Coronavirus disease 2019 (COVID-19) seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking. Clin Infect Dis. 2021;73(Suppl 2):S154–S162. doi: 10.1093/cid/ciaa1684.
  • Cordova E, Bacelar B, Nieto F, et al. SARS-CoV-2 IgG response in symptomatic and asymptomatic COVID-19-infected healthcare workers. Occup Med (Lond). 2021;71(4-5):215–218. doi: 10.1093/occmed/kqab061.
  • Movsisyan M, Chopikyan A, Kasparova I, et al. Kinetics of anti-nucleocapsid IgG response in COVID-19 immunocompetent convalescent patients. Sci Rep. 2022;12(1):12403. doi: 10.1038/s41598-022-16402-0.
  • Olariu TR, Lighezan R, Ursoniu S, et al. High SARS-CoV-2 seroprevalence in blood donors from Romania after the third COVID-19 pandemic wave. Infect Dis (Lond). 2022;54(7):534–537. doi: 10.1080/23744235.2022.2036811.
  • Papagiannis D, Kotsiou OS, Fradelos EC, et al. Work place and prevalence of COVID-19 in a rural population in Greece. Rural Remote Health. 2022;22(3):6751. doi: 10.22605/RRH6751.
  • Dimopoulou D, Kyritsi M, Dadouli K, et al. Seroprevalence of anti‑SARS‑CoV‑2 antibodies among children and their parents in Greece. Eur J Pediatr. 2023;182(1):439–449. doi: 10.1007/s00431-022-04681-8.
  • Ristić M, Vuković V, Patić A, et al. Seroepidemiology of SARS-CoV-2 virus in healthcare workers before circulation of the omicron sublineages BA.4/BA.5 in Vojvodina, Serbia. Vaccines (Basel). 2022;10(12):2168. doi: 10.3390/vaccines10122168.